OTC : AKBLF

ALK-Abelló A/S

$37.915 USD

$0 (0.0%)

Volume
105
Average Volume
26
Market Capitalization
$7.63B
P/E Ratio
37.23
Dividend Yield
0.74%
Price Target
Year High
$40.65
Year Low
$28.95
Day High
—
Day Low
—
Payout Ratio
$0.28
Current Ratio
$3.25
Company Overview

OTC

Peter Halling

Biotechnology

Healthcare

AKBLF

2759

DK

USD

https://www.alk.net

45 45 74 75 76

N/A

N/A

Liquidity Metrics

0.06

3.25

2.01

1.08

0.28

Sales & Valuation

$6.3B

7.25

7.25

26.11

8.23

Profitability

$5.41

$1.19B

19.51%

26.60%

20.45%

13.78%

P/E Metrics

37.23

1.07

1.07

Analyst Price Target & Rating

N/A

0/5

1 Analysts

%

Financial Health Scores

13.63

7/9

$3.23B

$9.3B

$2.72B

$1.75B

Key Metrics (TTM)

$47.13B

7.18

22.28

3.25

20.45%

16.25%

2.65%

3.78%

$62.07

339 days

Company Executives
Name Title
Peter Halling President, Chief Executive Officer & Member of Management Board
Katja Barnkob Thalund Senior Project Director, Global Clinical Development & Employee-elected Director
Lika Thiesen Executive Vice President of Global People & Organisation
Lise Lund Maerkedahl Project Director of Global Clinical Development & Employee-elected Director
Nanna Rassov Carlson Senior Manager of QA Release & Employee Representative Director
Hendrik Kees Kam Nolte Senior Vice President of Research & Development - North America and International Markets
Johan Smedsrud Senior Maintenance Supporter of Process & Production Support & Employee Representative Director
Per Plotnikof Vice President of Corporate Communications, Investor Relations & Strategic Planning and Head of IR
Søren Daniel Niegel Member of Management Board
Claus Steensen Solje Executive Vice President, Chief Financial Officer & Member of Management Board
Poll Results

No votes yet today — be the first to share your view!

About ALK-Abelló A/S (OTC:AKBLF) Stock

Established in 1923 and headquartered in Hørsholm, Denmark, ALK-Abelló A/S is a global pharmaceutical enterprise specializing in allergy treatment. The company provides a comprehensive range of allergy solutions to markets across Europe, North America, and other international regions. These offerings include immunotherapy products delivered through injections, sublingual drops, and oral tablets, designed to address various allergies such as those caused by house dust mites, grass, tree, ragweed, and Japanese cedar. ALK-Abelló also manufactures adrenaline auto-injectors for the critical management of severe allergic reactions and produces diagnostic tools essential for identifying allergic conditions. Their product portfolio features notable treatments like GRAZAX, RAGWITEK, RAGWIZAX, MITIC ... URE, ODACTRA, CEDARCURE, and ITULAZAX, all aimed at allergic rhinitis, as well as ACARIZAX, which targets both allergic rhinitis and allergic asthma.

ALK-Abelló A/S (AKBLF) Q1 2026 Earnings Call Transcript

2026-05-04 17:43:24

ALK-Abelló A/S (AKBLF) Q1 2026 Earnings Call Transcript

Frequently Asked Questions

What is the current ALK-Abelló A/S (AKBLF) stock price?

ALK-Abelló A/S(OTC:AKBLF) stock price is $37.915 in the last trading session. During the trading session, AKBLF stock reached the peak price of $40.65 while $28.95 was the lowest point it dropped to. The percentage change in AKBLF stock occurred in the recent session was 0.0% while the dollar amount for the price change in AKBLF stock was $0.

AKBLF's industry and sector of operation?

The OTC listed AKBLF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of AKBLF?

Peter Halling | President, Chief Executive Officer & Member of Management Board
Katja Barnkob Thalund | Senior Project Director, Global Clinical Development & Employee-elected Director
Lika Thiesen | Executive Vice President of Global People & Organisation
Lise Lund Maerkedahl | Project Director of Global Clinical Development & Employee-elected Director
Nanna Rassov Carlson | Senior Manager of QA Release & Employee Representative Director

How many employees does AKBLF have?

Number of AKBLF employees currently stands at 2759. AKBLF operates from Boge Alle 6-8, Horsholm, CR 2970, DK.

Link for AKBLF official website?

Official Website of AKBLF is: https://www.alk.net

How do I contact AKBLF?

AKBLF could be contacted at phone #45 45 74 75 76 and can also be accessed through its website. AKBLF operates from Boge Alle 6-8, Horsholm, CR 2970, DK.

How many shares of AKBLF are traded daily?

The average number of AKBLF shares traded daily for last 3 months was 26.

What is the market cap of AKBLF currently?

The market value of AKBLF currently stands at $7.63B with its latest stock price at $37.915